Literature DB >> 10845936

Posttranscriptional cell cycle-dependent regulation of human FANCC expression.

M C Heinrich1, K V Silvey, S Stone, A J Zigler, D J Griffith, M Montalto, L Chai, Y Zhi, M E Hoatlin.   

Abstract

The Fanconi Anemia (FA) Group C complementation group gene (FANCC) encodes a protein, FANCC, with a predicted M(r) of 63,000 daltons. FANCC is found in both the cytoplasmic and the nuclear compartments and interacts with certain other FA complementation group proteins as well as with non-FA proteins. Despite intensive investigation, the biologic roles of FANCC and of the other cloned FA gene products (FANCA and FANCG) remain unknown. As an approach to understanding FANCC function, we have studied the molecular regulation of FANCC expression. We found that although FANCC mRNA levels are constant throughout the cell cycle, FANCC is expressed in a cell cycle-dependent manner, with the lowest levels seen in cells synchronized at the G1/S boundary and the highest levels in the M-phase. Cell cycle-dependent regulation occurred despite deletion of the 5' and 3' FANCC untranslated regions, indicating that information in the FANCC coding sequence is sufficient to mediate cell cycle-dependent regulation. Moreover, inhibitors of proteasome function blocked the observed regulation. We conclude that FANCC expression is controlled by posttranscriptional mechanisms that are proteasome dependent. Recent work has demonstrated that the functional activity of FA proteins requires the physical interaction of at least FANCA, FANCC, and FANCG, and possibly of other FA and non-FA proteins. Our observation of dynamic control of FANCC expression by the proteasome has important implications for understanding the molecular regulation of the multiprotein complex. (Blood. 2000;95:3970-3977)

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10845936

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  A multiprotein nuclear complex connects Fanconi anemia and Bloom syndrome.

Authors:  Amom Ruhikanta Meetei; Salvatore Sechi; Michael Wallisch; Dafeng Yang; Mary K Young; Hans Joenje; Maureen E Hoatlin; Weidong Wang
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  UBE2T, the Fanconi anemia core complex, and FANCD2 are recruited independently to chromatin: a basis for the regulation of FANCD2 monoubiquitination.

Authors:  Arno Alpi; Frederic Langevin; Georgina Mosedale; Yuichi J Machida; Anindya Dutta; Ketan J Patel
Journal:  Mol Cell Biol       Date:  2007-10-15       Impact factor: 4.272

Review 3.  Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.

Authors:  T Yamashita; T Nakahata
Journal:  Int J Hematol       Date:  2001-07       Impact factor: 2.490

4.  FANCC deficiency mediates microglial pyroptosis and secondary neuronal apoptosis in spinal cord contusion.

Authors:  Mingjie Xia; Xinyu Li; Suhui Ye; Qinyang Zhang; Tianyu Zhao; Rulin Li; Yanan Zhang; Minghan Xian; Tianqi Li; Haijun Li; Xin Hong; Shengnai Zheng; Zhanyang Qian; Lei Yang
Journal:  Cell Biosci       Date:  2022-06-03       Impact factor: 9.584

5.  Borealin is repressed in response to p53/Rb signaling.

Authors:  Dipali A Date; Cara J Jacob; Mike E Bekier; Andrew C Stiff; Mark W Jackson; William R Taylor
Journal:  Cell Biol Int       Date:  2007-07-15       Impact factor: 3.612

6.  Enhanced TNF-alpha-induced apoptosis in Fanconi anemia type C-deficient cells is dependent on apoptosis signal-regulating kinase 1.

Authors:  Khadijeh Bijangi-Vishehsaraei; M Reza Saadatzadeh; Adam Werne; Kristina A Wilson McKenzie; Reuben Kapur; Hidenori Ichijo; Laura S Haneline
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

7.  Analysis of mitotic phosphorylation of borealin.

Authors:  Harpreet Kaur; Andrew C Stiff; Dipali A Date; William R Taylor
Journal:  BMC Cell Biol       Date:  2007-01-22       Impact factor: 4.241

Review 8.  The ubiquitin-proteasome system in cancer, a major player in DNA repair. Part 1: post-translational regulation.

Authors:  Panagiotis J Vlachostergios; Anna Patrikidou; Danai D Daliani; Christos N Papandreou
Journal:  J Cell Mol Med       Date:  2009-06-11       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.